The company actually beat Wall Street profit estimates largely thanks to its superstar cancer immunotherapy drug Keytruda, which has been shown to best chemotherapy in
helping lung cancer patients live longer and given Merck a leg up over rivals like Bristol - Myers Squibb's immune therapy Opdivo.
Not exact matches
The medicines, which
help unleash the immune system on
cancer cells, were tested in
patients with advanced
lung cancer.
«We feel it'll be able to
help kill
cancer cells in 80 percent of breast
cancer patients,» said Dr. Olson, who added that their antibody has the potential to
help kill
lung, colon, prostate and other
cancer cells, too.
«In the 20 years that I've been in practice, I consider this a major milestone,» she adds, noting that the trial results
helped achieve U.S. Food and Drug Administration approval in March to treat such
patients whose
lung cancer progressed, despite standard chemotherapy.
«Process to
help personalize treatment for
lung cancer patients developed.»
«Our findings suggest that this new drug combination would also
help patients with this type of aggressive breast
cancer as well as other
cancers, such as
lung, prostate and ovarian
cancers,» Dr. Rassool says.
Identification of a specific genetic mutation in
patients with non-small-cell
lung cancer (NSCLC)
helps clinicians select the best treatment option.
UT Southwestern Medical Center researchers are developing a new predictive tool that could
help patients with breast
cancer and certain
lung cancers decide whether follow - up treatments are likely to
help.
The results of these animal trials may eventually
help patients with colon, rectum, stomach, breast, or
lung cancer.
One early project was to
help Genoptix — a Novartis daughter - company acquired in 2011 and located in Carlsbad, California — to commercialize a diagnostic test for
lung cancer patients.
Most
lung cancer patients undergo 4D CT as standard - of - care to
help radiation oncologists develop a personalized plan to account for breathing motion during therapy.
Patients undergoing surgery for lung cancer may wait too long to receive treatment, and too many patients skip vital diagnostic steps that are needed to help determine the best possible treatment, according to an article in the August 2015 issue of The Annals of Thoracic
Patients undergoing surgery for
lung cancer may wait too long to receive treatment, and too many
patients skip vital diagnostic steps that are needed to help determine the best possible treatment, according to an article in the August 2015 issue of The Annals of Thoracic
patients skip vital diagnostic steps that are needed to
help determine the best possible treatment, according to an article in the August 2015 issue of The Annals of Thoracic Surgery.
City of Hope
patients have access to a wide variety of clinical trials looking into early - detection for
lung cancer, the newest chemotherapy treatments, targeted therapies and surgical and radiation approaches — all with the goal of
helping extend life.
If the drug proves successful in humans, the researchers hope that it could
help patients with this kind of
lung cancer to live longer.
Madison, WI About Blog Free to Breathe is a non-profit raising vital
lung cancer research funding with nationwide event series and
helping patients with free resources.